aoki2010duration
stool_norovirus
|
norovirus |
stool | symptom onset |
exponential |
7.09 | gc/wet gram |
0.51 |
2.15 |
13 |
57 |
25 |
105.5 |
arts2023longitudinal
stool_SARSCoV2_N
|
SARS-CoV-2 |
stool | symptom onset |
exponential |
5.02 | gc/dry gram |
1.04 |
1.33 |
34 |
290 |
98 |
759.5 |
arts2023longitudinal
stool_SARSCoV2_N
|
SARS-CoV-2 |
stool | symptom onset |
gamma |
4.3 | gc/dry gram |
0.83 |
1.33 |
29 |
275 |
95 |
666.7 |
arts2023longitudinal
stool_SARSCoV2_N
|
SARS-CoV-2 |
stool | symptom onset |
gamma shifted |
4.11 | gc/dry gram |
0.74 |
1.33 |
28 |
274 |
94 |
668.7 |
arts2023longitudinal
stool_SARSCoV2_ORF1a
|
SARS-CoV-2 |
stool | symptom onset |
exponential |
4.46 | gc/dry gram |
1.12 |
1.31 |
35 |
297 |
107 |
814.0 |
arts2023longitudinal
stool_SARSCoV2_ORF1a
|
SARS-CoV-2 |
stool | symptom onset |
gamma |
4.18 | gc/dry gram |
0.87 |
1.31 |
30 |
282 |
104 |
713.1 |
arts2023longitudinal
stool_SARSCoV2_ORF1a
|
SARS-CoV-2 |
stool | symptom onset |
gamma shifted |
3.85 | gc/dry gram |
0.81 |
1.31 |
29 |
281 |
104 |
729.7 |
atmar2008norwalk
stool_norovirus
|
norovirus |
stool | enrollment |
exponential |
10.83 | gc/dry gram |
0.69 |
7.6 |
16 |
182 |
33 |
412.7 |
atmar2008norwalk
stool_norovirus
|
norovirus |
stool | enrollment |
gamma |
10.35 | gc/dry gram |
0.57 |
7.6 |
16 |
182 |
33 |
381.9 |
brint2017prolonged
nasal_aspirate_respiratory_syncytial_virus_viral_load
|
RSV |
nasopharyngeal_aspirate | symptom onset |
exponential |
6.96 | pfu/mL |
1.16 |
-0.01 |
25 |
212 |
30 |
695.0 |
cdc2024nhphrn
NP_SARSCoV2_VL
|
SARS-CoV-2 |
nasopharyngeal_swab | confirmation date |
exponential |
7.12 | gc/mL |
1.0 |
4.0 |
78 |
1278 |
596 |
2390.5 |
cdc2024nhphrn
NP_SARSCoV2_VL
|
SARS-CoV-2 |
nasopharyngeal_swab | confirmation date |
gamma |
6.85 | gc/mL |
0.94 |
4.0 |
75 |
1235 |
589 |
2299.2 |
cdc2024nhphrn
NP_SARSCoV2_VL
|
SARS-CoV-2 |
nasopharyngeal_swab | confirmation date |
gamma shifted |
7.17 | gc/mL |
0.94 |
4.0 |
75 |
1265 |
589 |
2528.2 |
chilengi2020pilot
stool_rotavirus_viral_load
|
rotavirus |
stool | vaccination |
exponential |
6.94 | gc/wet gram |
1.08 |
1.59 |
16 |
43 |
8 |
175.2 |
cowley2017rotavirus
stool_rotavirus_vaccine_dose1
|
rotavirus vaccine |
stool | vaccination |
exponential |
9.92 | gc/wet gram |
1.0 |
2.0 |
13 |
80 |
44 |
172.9 |
cowley2017rotavirus
stool_rotavirus_vaccine_dose2
|
rotavirus vaccine |
stool | vaccination |
exponential |
9.0 | gc/wet gram |
0.98 |
2.0 |
12 |
73 |
42 |
148.3 |
cowley2017rotavirus
stool_rotavirus_vaccine_dose3
|
rotavirus vaccine |
stool | vaccination |
exponential |
8.66 | gc/wet gram |
0.93 |
2.0 |
9 |
44 |
22 |
106.1 |
el2011respiratory
respiratory_secretions_RSV_viral_load
|
RSV |
nasopharyngeal_aspirate | enrollment |
exponential |
6.63 | pfu/mL |
0.39 |
0.75 |
8 |
30 |
4 |
60.4 |
enya2023similarities
1_gc_reaction
|
rotavirus vaccine |
stool | vaccination |
gamma |
7.29 | gc/reaction |
0.48 |
1.78 |
20 |
156 |
9 |
329.4 |
enya2023similarities
2_gc_reaction
|
rotavirus vaccine |
stool | vaccination |
exponential |
4.64 | gc/reaction |
1.14 |
2.22 |
20 |
171 |
50 |
513.9 |
enya2023similarities
2_gc_reaction
|
rotavirus vaccine |
stool | vaccination |
gamma shifted |
5.63 | gc/reaction |
0.68 |
2.22 |
20 |
161 |
40 |
440.0 |
fajnzylber2020sars
Nasopharyngeal_SARSCoV2_N
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
exponential |
5.45 | gc/mL |
0.89 |
1.6 |
16 |
39 |
16 |
138.2 |
fajnzylber2020sars
Oropharyngeal_PBS_SARSCoV2_N
|
SARS-CoV-2 |
oropharyngeal_swab | symptom onset |
exponential |
4.94 | gc/mL |
0.34 |
1.6 |
10 |
24 |
5 |
58.3 |
fajnzylber2020sars
Sputum_SARSCoV2_N
|
SARS-CoV-2 |
sputum | symptom onset |
exponential |
7.57 | gc/mL |
0.45 |
1.6 |
15 |
36 |
6 |
105.1 |
falsey2003comparison
nasal_respiratory_syncytial_virus_quant_rt_pcr
|
RSV |
nasal_lavage_fluid | inoculation |
exponential |
1.61 | pfu/mL |
1.75 |
1.0 |
11 |
154 |
83 |
418.2 |
falsey2003comparison
nasal_respiratory_syncytial_virus_quant_rt_pcr
|
RSV |
nasal_lavage_fluid | inoculation |
gamma |
2.54 | pfu/mL |
0.87 |
1.0 |
11 |
143 |
72 |
299.3 |
fraaij2015viral
particles_ml
|
influenza |
nasopharyngeal_swab+oropharyngeal_swab | enrollment |
exponential |
5.71 | vp/mL |
1.03 |
2.79 |
4 |
14 |
2 |
54.1 |
garciaknight2022infectious
e
|
SARS-CoV-2 |
anterior_nares_swab | symptom onset |
exponential |
6.42 | gc/mL |
1.08 |
0.26 |
74 |
529 |
0 |
1885.3 |
garciaknight2022infectious
e
|
SARS-CoV-2 |
anterior_nares_swab | symptom onset |
gamma |
6.4 | gc/mL |
0.94 |
0.26 |
66 |
503 |
0 |
1767.1 |
garciaknight2022infectious
e
|
SARS-CoV-2 |
anterior_nares_swab | symptom onset |
gamma shifted |
5.88 | gc/mL |
0.9 |
0.26 |
63 |
503 |
0 |
1822.7 |
garciaknight2022infectious
n
|
SARS-CoV-2 |
anterior_nares_swab | symptom onset |
exponential |
6.41 | gc/mL |
0.95 |
0.26 |
66 |
440 |
2 |
1469.8 |
garciaknight2022infectious
n
|
SARS-CoV-2 |
anterior_nares_swab | symptom onset |
gamma |
5.9 | gc/mL |
0.82 |
0.26 |
62 |
424 |
2 |
1408.8 |
garciaknight2022infectious
n
|
SARS-CoV-2 |
anterior_nares_swab | symptom onset |
gamma shifted |
5.62 | gc/mL |
0.78 |
0.26 |
58 |
419 |
2 |
1447.1 |
golantripto2024viral
utm_vp_ml_nasopharyngeal_swab
|
RSV |
nasopharyngeal_swab | hospital admission |
exponential |
5.67 | vp/mL |
0.11 |
2.59 |
12 |
24 |
0 |
13.3 |
golantripto2024viral
vcm_vp_ml_nasopharyngeal_swab
|
RSV |
nasopharyngeal_swab | hospital admission |
exponential |
5.54 | vp/mL |
0.2 |
2.39 |
12 |
24 |
0 |
41.4 |
golantripto2024viral
utm_vp_ml_nasal_lavage_fluid
|
RSV |
nasal_lavage_fluid | hospital admission |
exponential |
7.42 | vp/mL |
0.06 |
4.39 |
12 |
24 |
0 |
-17.3 |
golantripto2024viral
vcm_vp_ml_nasal_lavage_fluid
|
RSV |
nasal_lavage_fluid | hospital admission |
exponential |
7.45 | vp/mL |
0.03 |
4.29 |
12 |
24 |
0 |
-46.7 |
hakki2022onset
asymptomatic_PCR
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | enrollment |
exponential |
5.64 | gc/mL |
2.65 |
1.5 |
17 |
242 |
96 |
894.1 |
hakki2022onset
asymptomatic_PCR
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | enrollment |
gamma |
5.97 | gc/mL |
1.59 |
1.5 |
16 |
223 |
85 |
700.6 |
hakki2022onset
asymptomatic_PCR
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | enrollment |
gamma shifted |
6.22 | gc/mL |
1.51 |
1.5 |
16 |
228 |
85 |
733.6 |
hakki2022onset
asymptomatic_cultivable
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | enrollment |
exponential |
1.54 | pfu/mL |
1.97 |
0.99 |
14 |
214 |
162 |
377.0 |
hakki2022onset
asymptomatic_cultivable
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | enrollment |
gamma |
1.76 | pfu/mL |
1.22 |
0.99 |
12 |
186 |
138 |
290.3 |
hakki2022onset
asymptomatic_cultivable
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | enrollment |
gamma shifted |
1.5 | pfu/mL |
1.2 |
0.99 |
13 |
200 |
150 |
327.8 |
hakki2022onset
symptomatic_PCR
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | symptom onset |
exponential |
6.4 | gc/mL |
2.42 |
1.82 |
33 |
452 |
105 |
1905.9 |
hakki2022onset
symptomatic_PCR
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | symptom onset |
gamma |
7.95 | gc/mL |
0.85 |
1.9 |
32 |
340 |
56 |
948.4 |
hakki2022onset
symptomatic_PCR
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | symptom onset |
gamma shifted |
7.64 | gc/mL |
0.95 |
1.82 |
33 |
403 |
56 |
1256.8 |
hakki2022onset
symptomatic_cultivable
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | symptom onset |
exponential |
2.19 | pfu/mL |
2.06 |
0.99 |
31 |
426 |
248 |
1118.2 |
hakki2022onset
symptomatic_cultivable
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | symptom onset |
gamma |
4.09 | pfu/mL |
0.66 |
0.99 |
30 |
322 |
173 |
515.6 |
hakki2022onset
symptomatic_cultivable
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | symptom onset |
gamma shifted |
4.08 | pfu/mL |
0.73 |
0.99 |
30 |
349 |
173 |
663.9 |
hu2013association
oropharyngeal_swab
|
influenza |
oropharyngeal_swab | symptom onset |
exponential |
5.0 | gc/swab |
1.3 |
2.14 |
13 |
133 |
92 |
237.8 |
hu2013association
oropharyngeal_swab
|
influenza |
oropharyngeal_swab | symptom onset |
gamma |
4.87 | gc/swab |
1.27 |
2.14 |
13 |
133 |
92 |
261.3 |
hu2013association
urine
|
influenza |
urine | symptom onset |
exponential |
3.7 | gc/mL |
0.61 |
2.25 |
11 |
76 |
55 |
121.8 |
hu2013association
urine
|
influenza |
urine | symptom onset |
gamma |
3.29 | gc/mL |
0.61 |
2.25 |
11 |
76 |
55 |
143.1 |
hu2013association
stool
|
influenza |
stool | symptom onset |
exponential |
3.92 | gc/wet gram |
1.15 |
2.15 |
11 |
76 |
51 |
160.5 |
hu2013association
stool
|
influenza |
stool | symptom onset |
gamma |
3.71 | gc/wet gram |
1.12 |
2.15 |
11 |
76 |
51 |
181.2 |
iwakiri2009quantitative
stool_SaV
|
sapovirus |
stool | symptom onset |
exponential |
8.7 | gc/wet gram |
0.16 |
5.11 |
17 |
41 |
19 |
52.0 |
kay2011shedding
nasal_lavage_influenza_gc_per_mL
|
influenza |
nasal_lavage_fluid | symptom onset |
exponential |
8.09 | gc/mL |
0.34 |
3.0 |
8 |
37 |
0 |
59.2 |
ke2022daily
nasal_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
exponential |
6.63 | gc/mL |
1.2 |
0.89 |
60 |
795 |
138 |
2515.3 |
ke2022daily
nasal_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
gamma |
6.19 | gc/mL |
0.89 |
0.89 |
59 |
731 |
123 |
2079.7 |
ke2022daily
nasal_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
gamma shifted |
6.58 | gc/mL |
0.89 |
0.89 |
60 |
792 |
135 |
2327.8 |
ke2022daily
saliva_SARSCoV2
|
SARS-CoV-2 |
saliva | symptom onset |
exponential |
6.33 | gc/mL |
1.46 |
3.06 |
60 |
883 |
216 |
2945.3 |
ke2022daily
saliva_SARSCoV2
|
SARS-CoV-2 |
saliva | symptom onset |
gamma |
7.09 | gc/mL |
0.76 |
3.06 |
59 |
727 |
163 |
1777.6 |
ke2022daily
saliva_SARSCoV2
|
SARS-CoV-2 |
saliva | symptom onset |
gamma shifted |
7.49 | gc/mL |
0.74 |
3.06 |
60 |
843 |
176 |
2125.3 |
kirby2016vomiting
emesis_norovirus_GII
|
norovirus |
emesis | symptom onset |
exponential |
3.04 | gc/mL |
0.86 |
-2.37 |
3 |
16 |
1 |
55.0 |
kissler2021viral
AN_OPS_SARSCoV2_viral
|
SARS-CoV-2 |
anterior_nares_swab+oropharyngeal_swab | confirmation date |
exponential |
3.77 | gc/mL |
1.79 |
2.66 |
67 |
2173 |
1948 |
1495.8 |
kissler2021viral
AN_OPS_SARSCoV2_viral
|
SARS-CoV-2 |
anterior_nares_swab+oropharyngeal_swab | confirmation date |
gamma |
5.7 | gc/mL |
0.74 |
2.66 |
51 |
1679 |
1525 |
776.7 |
kissler2021viral
AN_OPS_SARSCoV2_viral
|
SARS-CoV-2 |
anterior_nares_swab+oropharyngeal_swab | confirmation date |
gamma shifted |
5.7 | gc/mL |
0.79 |
2.66 |
60 |
2072 |
1858 |
1129.9 |
kondo2016influenza
nasal_discharge_influenza_gc_per_mL
|
influenza |
nasal_discharge | symptom onset |
exponential |
6.5 | gc/mL |
0.59 |
3.5 |
28 |
84 |
29 |
229.3 |
kondo2016influenza
nasal_discharge_influenza_gc_per_mL
|
influenza |
nasal_discharge | symptom onset |
gamma |
6.08 | gc/mL |
0.28 |
3.5 |
19 |
57 |
19 |
132.4 |
lavezzo2020suppression
RdRp_first_pos
|
SARS-CoV-2 |
oropharyngeal_swab | confirmation date |
exponential |
3.07 | gc/mL |
0.06 |
1.42 |
44 |
88 |
36 |
38.1 |
lavezzo2020suppression
E_first_pos
|
SARS-CoV-2 |
oropharyngeal_swab | confirmation date |
exponential |
4.17 | gc/mL |
2.74 |
0.73 |
40 |
80 |
28 |
423.7 |
lavezzo2020suppression
RdRp_symptom
|
SARS-CoV-2 |
oropharyngeal_swab | symptom onset |
exponential |
3.73 | gc/mL |
0.0 |
1.36 |
38 |
76 |
26 |
-372.3 |
lavezzo2020suppression
E_symptom
|
SARS-CoV-2 |
oropharyngeal_swab | symptom onset |
exponential |
4.36 | gc/mL |
0.71 |
0.87 |
46 |
92 |
28 |
352.7 |
lescure2020clinical
naso_swab_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
exponential |
7.71 | gc/swab |
0.72 |
2.0 |
4 |
34 |
11 |
71.3 |
li2018faecal
stool_lanzhou_lamb_rotavirus_vaccine_pcr
|
Lanzhou lamb rotavirus vaccine |
stool | vaccination |
exponential |
4.44 | gc/wet gram |
2.0 |
3.0 |
15 |
50 |
22 |
209.1 |
liu2024longitudinal
stool_SARSCoV2_N1
|
SARS-CoV-2 |
stool | confirmation date |
exponential |
6.18 | gc/dry gram |
1.17 |
3.0 |
16 |
69 |
36 |
194.5 |
liu2024longitudinal
stool_SARSCoV2_N1
|
SARS-CoV-2 |
stool | confirmation date |
gamma |
5.77 | gc/dry gram |
0.87 |
3.0 |
15 |
67 |
35 |
193.6 |
lui2020viral
2019-nCoV_N1
|
SARS-CoV-2 |
stool | symptom onset |
exponential |
5.72 | gc/mL |
0.4 |
2.84 |
9 |
41 |
20 |
72.0 |
lui2020viral
2019-nCoV_N1
|
SARS-CoV-2 |
stool | symptom onset |
gamma |
4.58 | gc/mL |
0.4 |
2.84 |
8 |
39 |
19 |
82.7 |
mijatovicrustempasic2017shedding
stool_rotavirus_vaccine
|
rotavirus vaccine |
stool | vaccination |
exponential |
5.65 | gc/mL |
1.73 |
2.07 |
30 |
265 |
111 |
818.5 |
mijatovicrustempasic2017shedding
stool_rotavirus_vaccine
|
rotavirus vaccine |
stool | vaccination |
gamma |
5.58 | gc/mL |
1.5 |
2.07 |
29 |
263 |
110 |
809.2 |
mijatovicrustempasic2017shedding
stool_pcv1_dna
|
rotavirus vaccine |
stool | vaccination |
exponential |
4.19 | gc/mL |
0.77 |
2.17 |
23 |
201 |
160 |
228.4 |
miyoshi2015long
stool_norovirus
|
norovirus |
stool | symptom onset |
exponential |
7.47 | gc/wet gram |
0.81 |
3.62 |
4 |
37 |
4 |
101.4 |
natarajan2022gastrointestinal
E-gRNA-RT-qPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
exponential |
3.79 | gc/mL |
0.34 |
3.0 |
52 |
312 |
199 |
358.8 |
natarajan2022gastrointestinal
E-gRNA-RT-qPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
gamma |
3.4 | gc/mL |
0.26 |
3.0 |
42 |
272 |
182 |
296.3 |
natarajan2022gastrointestinal
E-gRNA-RT-qPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
gamma shifted |
3.72 | gc/mL |
0.23 |
3.0 |
45 |
296 |
196 |
382.0 |
natarajan2022gastrointestinal
E-gRNA-RT-qPCR-ZY
|
SARS-CoV-2 |
stool | enrollment |
exponential |
4.9 | gc/mL |
0.44 |
3.0 |
54 |
358 |
202 |
457.6 |
natarajan2022gastrointestinal
RdRP-gRNA-RT-qPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
exponential |
3.75 | gc/mL |
0.33 |
3.0 |
32 |
194 |
124 |
218.4 |
natarajan2022gastrointestinal
RdRP-gRNA-RT-qPCR-ZY
|
SARS-CoV-2 |
stool | enrollment |
exponential |
4.8 | gc/mL |
0.29 |
3.0 |
45 |
306 |
182 |
274.8 |
natarajan2022gastrointestinal
RdRP-gRNA-RT-qPCR-ZY
|
SARS-CoV-2 |
stool | enrollment |
gamma |
4.75 | gc/mL |
0.17 |
3.0 |
37 |
268 |
164 |
166.9 |
natarajan2022gastrointestinal
RdRP-gRNA-RT-qPCR-ZY
|
SARS-CoV-2 |
stool | enrollment |
gamma shifted |
4.56 | gc/mL |
0.16 |
3.0 |
40 |
296 |
182 |
250.7 |
natarajan2022gastrointestinal
N1-gRNA-RT-qPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
exponential |
4.28 | gc/mL |
0.5 |
3.0 |
71 |
392 |
174 |
756.2 |
natarajan2022gastrointestinal
N1-gRNA-RT-qPCR-ZY
|
SARS-CoV-2 |
stool | enrollment |
exponential |
4.86 | gc/mL |
0.42 |
3.0 |
76 |
476 |
244 |
682.9 |
natarajan2022gastrointestinal
N2-gRNA-RT-qPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
exponential |
3.85 | gc/mL |
0.33 |
3.0 |
62 |
344 |
178 |
397.8 |
natarajan2022gastrointestinal
N2-gRNA-RT-qPCR-ZY
|
SARS-CoV-2 |
stool | enrollment |
exponential |
4.53 | gc/mL |
0.41 |
3.0 |
57 |
372 |
192 |
477.4 |
natarajan2022gastrointestinal
N1-gRNA-ddPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
exponential |
3.2 | gc/mL |
0.54 |
3.0 |
63 |
209 |
99 |
470.6 |
natarajan2022gastrointestinal
N1-gRNA-ddPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
gamma shifted |
3.44 | gc/mL |
0.53 |
3.0 |
29 |
127 |
65 |
348.0 |
natarajan2022gastrointestinal
N1-gRNA-ddPCR-ZY
|
SARS-CoV-2 |
stool | enrollment |
exponential |
4.62 | gc/mL |
0.48 |
3.0 |
68 |
235 |
91 |
500.0 |
natarajan2022gastrointestinal
E-gRNA-ddPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
exponential |
3.08 | gc/mL |
0.44 |
3.0 |
18 |
41 |
16 |
111.8 |
natarajan2022gastrointestinal
E-gRNA-ddPCR-ZY
|
SARS-CoV-2 |
stool | enrollment |
exponential |
5.24 | gc/mL |
0.36 |
3.0 |
16 |
35 |
3 |
93.1 |
natarajan2022gastrointestinal
N1-sgRNA-RT-qPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
exponential |
3.92 | gc/mL |
1.14 |
3.0 |
20 |
124 |
85 |
234.0 |
natarajan2022gastrointestinal
N1-sgRNA-RT-qPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
gamma |
4.7 | gc/mL |
1.22 |
3.0 |
15 |
102 |
74 |
202.2 |
natarajan2022gastrointestinal
N1-sgRNA-RT-qPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
gamma shifted |
5.31 | gc/mL |
1.12 |
3.0 |
17 |
117 |
84 |
259.2 |
natarajan2022gastrointestinal
N1-sgRNA-RT-qPCR-ZY
|
SARS-CoV-2 |
stool | enrollment |
exponential |
5.61 | gc/mL |
1.35 |
3.0 |
42 |
214 |
111 |
562.9 |
peiris2003clinical
NPS_SARS
|
SARS |
nasopharyngeal_swab | symptom onset |
exponential |
6.92 | gc/mL |
1.15 |
2.98 |
14 |
42 |
0 |
188.8 |
pereira2022standardization
respiratory_influenzaA_viral_load
|
influenza |
nasopharyngeal_aspirate+nasopharyngeal_swab | symptom onset |
exponential |
6.25 | gc/reaction |
0.18 |
1.31 |
19 |
38 |
3 |
57.3 |
piccirilli2023respiratory
nasopharyngeal_aspirate_RSV_viral_load
|
RSV |
nasopharyngeal_aspirate | hospital admission |
exponential |
4.73 | gc/ng hDNA |
0.45 |
1.68 |
36 |
118 |
13 |
285.6 |
piralla2013different
nasopharyngeal_swab
|
influenza |
nasopharyngeal_swab | confirmation date |
exponential |
6.2 | gc/mL |
0.61 |
2.44 |
44 |
115 |
30 |
347.2 |
piralla2013different
bronchoalveolar_lavage_fluid
|
influenza |
bronchoalveolar_lavage_fluid | confirmation date |
exponential |
7.21 | gc/mL |
0.64 |
1.64 |
4 |
12 |
2 |
39.6 |
rodrigues2020influenza
respiratory_influenza_viral_load
|
influenza |
nasopharyngeal_swab+oropharyngeal_swab | treatment |
exponential |
7.09 | gc/mL |
0.86 |
2.09 |
10 |
33 |
7 |
112.9 |
rouphael2025effective
buccal_gc_ml
|
influenza |
buccal_swab | inoculation |
exponential |
2.75 | gc/mL |
1.19 |
2.7 |
5 |
35 |
28 |
64.3 |
rouphael2025effective
oropharyngeal_gc_ml
|
influenza |
oropharyngeal_swab | inoculation |
exponential |
3.09 | gc/mL |
1.85 |
2.7 |
7 |
49 |
24 |
161.5 |
rouphael2025effective
saliva_gc_ml
|
influenza |
saliva | inoculation |
exponential |
3.33 | gc/mL |
1.87 |
2.7 |
8 |
56 |
29 |
170.6 |
rouphael2025effective
anterior_nasal_pfu_ml
|
influenza |
anterior_nares_swab | inoculation |
exponential |
3.38 | pfu/mL |
2.3 |
0.7 |
5 |
35 |
15 |
132.8 |
rouphael2025effective
buccal_pfu_ml
|
influenza |
buccal_swab | inoculation |
exponential |
0.66 | pfu/mL |
0.79 |
0.7 |
3 |
21 |
17 |
35.0 |
rouphael2025effective
saliva_pfu_ml
|
influenza |
saliva | inoculation |
exponential |
2.61 | pfu/mL |
2.09 |
0.7 |
5 |
35 |
17 |
121.2 |
schumer2026viral
gc_ml
|
RSV |
nasopharyngeal_aspirate | inoculation |
exponential |
6.04 | gc/mL |
1.81 |
2.8 |
25 |
476 |
0 |
2015.9 |
schumer2026viral
gc_ml
|
RSV |
nasopharyngeal_aspirate | inoculation |
gamma |
5.96 | gc/mL |
1.22 |
2.8 |
25 |
476 |
0 |
1695.8 |
schumer2026viral
pfu_ml
|
RSV |
nasopharyngeal_aspirate | inoculation |
exponential |
3.45 | pfu/mL |
1.55 |
2.0 |
25 |
419 |
0 |
1657.5 |
schumer2026viral
pfu_ml
|
RSV |
nasopharyngeal_aspirate | inoculation |
gamma |
3.02 | pfu/mL |
1.3 |
2.0 |
25 |
419 |
0 |
1559.3 |
shetty2024influenza
nasopharyngeal_swab_pfu_ml
|
influenza |
nasopharyngeal_swab | inoculation |
exponential |
3.53 | pfu/mL |
1.75 |
1.23 |
5 |
30 |
13 |
102.9 |
shetty2024influenza
saliva_pfu_ml
|
influenza |
saliva | inoculation |
exponential |
3.18 | pfu/mL |
2.03 |
0.7 |
5 |
30 |
22 |
72.6 |
teunis2015shedding
stool_norovirus_concentration_symptomatic
|
norovirus |
stool | symptom onset |
exponential |
7.91 | gc/wet gram |
0.32 |
3.18 |
61 |
152 |
43 |
318.0 |
teunis2015shedding
stool_norovirus_concentration_asymptomatic
|
norovirus |
stool | confirmation date |
exponential |
6.34 | gc/wet gram |
0.53 |
3.59 |
25 |
57 |
18 |
168.3 |
tjon2006high
stool_hepatitis_A_virus
|
hepatitis A virus |
stool | symptom onset |
exponential |
7.77 | gc/mL |
0.66 |
2.0 |
3 |
23 |
10 |
40.3 |
tsang2016individual
NPSOPS
|
influenza |
nasopharyngeal_swab+oropharyngeal_swab | symptom onset |
exponential |
7.23 | gc/mL |
0.52 |
2.95 |
455 |
1131 |
0 |
3534.6 |
vetter2020daily
NPS_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
exponential |
8.05 | gc/mL |
1.02 |
3.26 |
5 |
39 |
2 |
132.2 |
vetter2020daily
NPS_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
gamma |
7.66 | gc/mL |
1.01 |
3.26 |
5 |
37 |
2 |
135.2 |
vetter2020daily
NPS_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
gamma shifted |
8.07 | gc/mL |
0.93 |
3.26 |
5 |
39 |
2 |
143.9 |
vetter2020daily
OPS_SARSCoV2
|
SARS-CoV-2 |
oropharyngeal_swab | symptom onset |
exponential |
7.66 | gc/mL |
0.94 |
2.37 |
5 |
35 |
1 |
116.4 |
walsh2013viral
pfu_ml
|
RSV |
anterior_nares_swab+sputum | symptom onset |
exponential |
4.85 | pfu/mL |
0.82 |
0.17 |
22 |
120 |
15 |
369.4 |
walsh2013viral
pfu_ml
|
RSV |
anterior_nares_swab+sputum | symptom onset |
gamma |
3.02 | pfu/mL |
0.72 |
0.17 |
22 |
120 |
15 |
381.1 |
woelfel2020virological
stool
|
SARS-CoV-2 |
stool | symptom onset |
exponential |
6.36 | gc/mL |
0.78 |
2.0 |
8 |
79 |
10 |
212.4 |
woelfel2020virological
stool
|
SARS-CoV-2 |
stool | symptom onset |
gamma |
4.92 | gc/mL |
0.77 |
2.0 |
8 |
79 |
10 |
223.8 |
woelfel2020virological
sputum
|
SARS-CoV-2 |
sputum | symptom onset |
exponential |
7.98 | gc/mL |
1.1 |
2.0 |
9 |
147 |
24 |
434.3 |
woelfel2020virological
oropharyngeal_swab
|
SARS-CoV-2 |
oropharyngeal_swab | symptom onset |
exponential |
6.51 | gc/swab |
1.05 |
2.0 |
9 |
153 |
57 |
342.4 |
xu2020characteristics
rectal_swab_SARSCoV2
|
SARS-CoV-2 |
rectal_swab | hospital admission |
exponential |
6.2 | gc/mL |
1.01 |
2.49 |
7 |
63 |
8 |
201.6 |
xu2020characteristics
rectal_swab_SARSCoV2
|
SARS-CoV-2 |
rectal_swab | hospital admission |
gamma shifted |
5.76 | gc/mL |
0.78 |
2.49 |
7 |
62 |
7 |
196.6 |
xu2020characteristics
nasopharyngeal_swab_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab | hospital admission |
exponential |
5.08 | gc/mL |
0.47 |
2.49 |
7 |
44 |
29 |
54.4 |
yen2011detection
stool_rotavirus_vaccine
|
rotavirus vaccine |
stool | vaccination |
exponential |
11.83 | gc/wet gram |
0.7 |
7.64 |
19 |
54 |
1 |
193.5 |
yen2011detection
stool_rotavirus_vaccine
|
rotavirus vaccine |
stool | vaccination |
gamma |
13.12 | gc/wet gram |
0.73 |
8.39 |
9 |
34 |
1 |
130.7 |
young2020epidemiologic
swab_SARSCoV2_N
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
exponential |
5.41 | gc/swab |
1.08 |
2.02 |
18 |
216 |
65 |
607.0 |
young2020epidemiologic
swab_SARSCoV2_N
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
gamma |
5.02 | gc/swab |
1.01 |
2.02 |
18 |
216 |
65 |
612.6 |
zuo2020alterations
stool_SARSCoV2_SymptomOnset
|
SARS-CoV-2 |
stool | symptom onset |
exponential |
6.53 | gc/mL |
0.88 |
2.54 |
9 |
31 |
13 |
92.3 |
alsharrah2020clinical
NPS_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
exponential |
14.11 |
cycles below 40 |
4.27 |
-1.0 |
11 |
43 |
22 |
184.6 |
brosius2023presymptomatic
genital_swab
|
mpox |
genital_swab |
exposure |
exponential |
4.72 |
cycles below 40 |
2.25 |
3.0 |
7 |
71 |
54 |
134.0 |
brosius2023presymptomatic
genital_swab
|
mpox |
genital_swab |
exposure |
gamma |
4.86 |
cycles below 40 |
2.16 |
3.0 |
7 |
71 |
54 |
145.7 |
cdc2024nhphrn
NP_SARSCoV2_CT
|
SARS-CoV-2 |
nasopharyngeal_swab |
confirmation date |
exponential |
19.99 |
cycles below 40 |
4.18 |
3.0 |
78 |
1278 |
596 |
4460.7 |
cdc2024nhphrn
NP_SARSCoV2_CT
|
SARS-CoV-2 |
nasopharyngeal_swab |
confirmation date |
gamma |
18.22 |
cycles below 40 |
3.8 |
3.0 |
75 |
1235 |
589 |
4234.9 |
cdc2024nhphrn
NP_SARSCoV2_CT
|
SARS-CoV-2 |
nasopharyngeal_swab |
confirmation date |
gamma shifted |
18.35 |
cycles below 40 |
3.76 |
3.0 |
75 |
1265 |
589 |
4534.7 |
coppee2023temporal
nasopharyngeal_swab_RSV_ct_symptomatic
|
RSV |
nasopharyngeal_swab |
symptom onset |
exponential |
21.47 |
cycles below 40 |
3.37 |
0.0 |
6 |
24 |
4 |
135.2 |
covid2020clinical
Stool_SARSCoV2
|
SARS-CoV-2 |
stool |
symptom onset |
exponential |
10.19 |
cycles below 40 |
1.79 |
0.0 |
7 |
34 |
13 |
122.9 |
covid2020clinical
OPS_SARSCoV2
|
SARS-CoV-2 |
oropharyngeal_swab |
symptom onset |
exponential |
10.01 |
cycles below 40 |
3.64 |
0.0 |
11 |
100 |
63 |
274.3 |
covid2020clinical
NPS_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
exponential |
10.2 |
cycles below 40 |
5.28 |
0.0 |
12 |
106 |
58 |
383.3 |
gautret2020hydroxychloroquine
nasopharyngeal_swab_SARSCoV2_Ct
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
exponential |
20.97 |
cycles below 40 |
3.27 |
5.0 |
19 |
126 |
44 |
530.4 |
hiramatsu2018rotavirus
rv5_1
|
rotavirus vaccine |
stool |
vaccination |
gamma |
12.49 |
cycles below 40 |
1.63 |
3.03 |
9 |
72 |
3 |
325.1 |
hiramatsu2018rotavirus
rv5_1
|
rotavirus vaccine |
stool |
vaccination |
gamma shifted |
12.41 |
cycles below 40 |
2.4 |
-4.27 |
9 |
73 |
3 |
404.1 |
kimse2020viral
oropharyngealswab_SARSCoV2_symptomatic
|
SARS-CoV-2 |
oropharyngeal_swab |
symptom onset |
exponential |
14.09 |
cycles below 40 |
3.49 |
0.0 |
3 |
21 |
5 |
106.8 |
kimse2020viral
oropharyngealswab_SARSCoV2_asymptomatic
|
SARS-CoV-2 |
oropharyngeal_swab |
confirmation date |
exponential |
7.3 |
cycles below 40 |
2.66 |
0.0 |
8 |
37 |
15 |
155.2 |
kissler2021densely
AN_OPS_SARSCoV2
|
SARS-CoV-2 |
anterior_nares_swab+oropharyngeal_swab |
confirmation date |
exponential |
3.39 |
cycles below 40 |
8.51 |
0.0 |
65 |
2402 |
1679 |
6634.8 |
kissler2021densely
AN_OPS_SARSCoV2
|
SARS-CoV-2 |
anterior_nares_swab+oropharyngeal_swab |
confirmation date |
gamma |
10.06 |
cycles below 40 |
4.21 |
0.0 |
65 |
1983 |
1351 |
4565.6 |
kissler2021densely
AN_OPS_SARSCoV2
|
SARS-CoV-2 |
anterior_nares_swab+oropharyngeal_swab |
confirmation date |
gamma shifted |
10.1 |
cycles below 40 |
4.44 |
0.0 |
65 |
2074 |
1351 |
5304.7 |
kissler2021viral
AN_OPS_SARSCoV2_ct
|
SARS-CoV-2 |
anterior_nares_swab+oropharyngeal_swab |
confirmation date |
exponential |
4.49 |
cycles below 40 |
6.36 |
0.0 |
67 |
2173 |
1948 |
2123.7 |
kissler2021viral
AN_OPS_SARSCoV2_ct
|
SARS-CoV-2 |
anterior_nares_swab+oropharyngeal_swab |
confirmation date |
gamma |
8.64 |
cycles below 40 |
2.79 |
0.0 |
51 |
1679 |
1525 |
1203.7 |
kissler2021viral
AN_OPS_SARSCoV2_ct
|
SARS-CoV-2 |
anterior_nares_swab+oropharyngeal_swab |
confirmation date |
gamma shifted |
8.65 |
cycles below 40 |
2.87 |
0.0 |
60 |
2072 |
1858 |
1686.6 |
kutter2021small
rsv_nasopharyngeal_aspirate_ct
|
RSV |
nasopharyngeal_aspirate |
symptom onset |
exponential |
19.38 |
cycles below 40 |
2.93 |
0.0 |
6 |
27 |
0 |
160.6 |
pace2024prevalence
stool_SARSCoV2
|
SARS-CoV-2 |
stool |
enrollment |
exponential |
8.87 |
cycles below 40 |
3.67 |
0.0 |
20 |
119 |
63 |
426.0 |
pace2024prevalence
stool_SARSCoV2
|
SARS-CoV-2 |
stool |
enrollment |
gamma |
9.03 |
cycles below 40 |
2.83 |
0.0 |
20 |
119 |
63 |
432.5 |
salvatore2020epidemiological
N1_probe
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
exponential |
15.33 |
cycles below 40 |
2.8 |
0.0 |
88 |
217 |
64 |
1129.3 |
salvatore2020epidemiological
N1_probe
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
gamma |
14.64 |
cycles below 40 |
2.29 |
0.0 |
22 |
75 |
19 |
394.9 |
schuurmans2014clinical
nasopharyngeal_swab_influenza_CT
|
influenza |
nasopharyngeal_swab |
symptom onset |
exponential |
11.71 |
cycles below 40 |
2.65 |
-1.76 |
16 |
54 |
0 |
324.5 |
seah2020assessing
nasopharyngeal_swab_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
exponential |
12.86 |
cycles below 40 |
3.22 |
0.6 |
17 |
134 |
26 |
667.0 |
seah2020assessing
nasopharyngeal_swab_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
gamma |
14.52 |
cycles below 40 |
3.11 |
0.6 |
17 |
134 |
26 |
691.7 |
shrestha2020distribution
swab_SARSCoV2_N_Ct
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
exponential |
18.36 |
cycles below 40 |
3.04 |
0.0 |
124 |
422 |
119 |
2121.5 |
tan2021early
swab_SARSCoV2_N
|
SARS-CoV-2 |
oropharyngeal_swab |
symptom onset |
exponential |
17.96 |
cycles below 40 |
3.8 |
3.5 |
11 |
81 |
24 |
381.8 |
tan2021early
swab_SARSCoV2_N
|
SARS-CoV-2 |
oropharyngeal_swab |
symptom onset |
gamma |
18.29 |
cycles below 40 |
2.77 |
3.5 |
11 |
79 |
23 |
356.2 |
tan2021early
swab_SARSCoV2_N
|
SARS-CoV-2 |
oropharyngeal_swab |
symptom onset |
gamma shifted |
18.36 |
cycles below 40 |
2.57 |
3.5 |
10 |
77 |
21 |
360.5 |
team2020clinical
naso_swab_SARSCoV2_N_Ct
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
exponential |
8.54 |
cycles below 40 |
6.16 |
-1.0 |
12 |
121 |
73 |
409.0 |
teunis2015shedding
stool_norovirus_ct_symptomatic
|
norovirus |
stool |
symptom onset |
exponential |
18.14 |
cycles below 40 |
1.43 |
0.0 |
61 |
152 |
43 |
648.5 |
teunis2015shedding
stool_norovirus_ct_asymptomatic
|
norovirus |
stool |
confirmation date |
exponential |
15.96 |
cycles below 40 |
2.51 |
0.0 |
25 |
57 |
18 |
290.3 |
wang2020fecal
stool_SARSCoV2_ORF1ab
|
SARS-CoV-2 |
stool |
symptom onset |
exponential |
12.58 |
cycles below 40 |
2.82 |
0.0 |
11 |
56 |
13 |
272.4 |
wang2020fecal
stool_SARSCoV2_N
|
SARS-CoV-2 |
stool |
symptom onset |
exponential |
13.75 |
cycles below 40 |
2.38 |
0.0 |
11 |
56 |
12 |
264.5 |
wang2020fecal
stool_SARSCoV2_N
|
SARS-CoV-2 |
stool |
symptom onset |
gamma |
12.61 |
cycles below 40 |
2.4 |
0.0 |
10 |
54 |
11 |
276.8 |
yang2020laboratory
upper_resp_tract
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab+sputum |
symptom onset |
exponential |
7.06 |
cycles below 40 |
5.49 |
2.0 |
25 |
248 |
146 |
857.1 |
yang2020laboratory
upper_resp_tract
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab+sputum |
symptom onset |
gamma |
8.18 |
cycles below 40 |
5.34 |
2.0 |
25 |
248 |
146 |
900.4 |
yang2020laboratory
lower_resp_tract
|
SARS-CoV-2 |
bronchoalveolar_lavage_fluid |
symptom onset |
exponential |
16.33 |
cycles below 40 |
3.31 |
2.0 |
13 |
76 |
19 |
375.9 |
yilmaz2020upper
oropharyngealswab_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab |
symptom onset |
exponential |
18.28 |
cycles below 40 |
3.73 |
0.0 |
54 |
349 |
80 |
1772.3 |
yuan2021sars
nasopharyngeal_swab_SARSCoV2_ORF1ab_symptomatic
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
exponential |
9.29 |
cycles below 40 |
7.44 |
0.0 |
6 |
84 |
56 |
261.6 |
yuan2021sars
nasopharyngeal_swab_SARSCoV2_N_symptomatic
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
exponential |
4.54 |
cycles below 40 |
6.96 |
0.0 |
6 |
84 |
52 |
285.2 |
yuan2021sars
stool_SARSCoV2_ORF1ab_symptomatic
|
SARS-CoV-2 |
stool |
symptom onset |
exponential |
9.84 |
cycles below 40 |
4.35 |
0.0 |
3 |
31 |
9 |
152.1 |
yuan2021sars
stool_SARSCoV2_ORF1ab_asymptomatic
|
SARS-CoV-2 |
stool |
confirmation date |
exponential |
11.19 |
cycles below 40 |
2.54 |
0.0 |
3 |
29 |
1 |
148.8 |
yuan2021sars
stool_SARSCoV2_N_symptomatic
|
SARS-CoV-2 |
stool |
symptom onset |
exponential |
8.59 |
cycles below 40 |
4.86 |
0.0 |
5 |
43 |
19 |
179.0 |
yuan2021sars
stool_SARSCoV2_N_symptomatic
|
SARS-CoV-2 |
stool |
symptom onset |
gamma |
6.89 |
cycles below 40 |
4.96 |
0.0 |
5 |
43 |
19 |
191.4 |
yuan2021sars
stool_SARSCoV2_N_asymptomatic
|
SARS-CoV-2 |
stool |
confirmation date |
exponential |
10.64 |
cycles below 40 |
2.53 |
0.0 |
3 |
29 |
1 |
148.3 |